A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer.

Spira, Alexander I; Iannotti, Nicholas O; Savin, Michael A; Neubauer, Marcus; Gabrail, Nashat Y; Yanagihara, Ronald H; Zang, Edith A; Cole, Patricia E; Shuster, Dale; Das, Asha

Spira, Alexander I; Iannotti, Nicholas O; Savin, Michael A; Neubauer, Marcus; Gabrail, Nashat Y; Yanagihara, Ronald H; Zang, Edith A; Cole, Patricia E; Shuster, Dale; Das, Asha.

Affiliation

Spira AI; Virginia Cancer Specialists, INOVA Thoracic Oncology Program, Fairfax, VA 22031, USA. Alexander.Spira@USOncology.com

Clin Lung Cancer ; 13(1): 31-8, 2012 Jan.

Article in En | MEDLINE | ID: mdl-21862415

Subject(s)

Adenocarcinoma/drug therapy; Carcinoma, Large Cell/drug therapy; Carcinoma, Non-Small-Cell Lung/drug therapy; Carcinoma, Squamous Cell/drug therapy; Furans/therapeutic use; Ketones/therapeutic use; Lung Neoplasms/drug therapy; Salvage Therapy; Adenocarcinoma/mortality; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell/mortality; Carcinoma, Non-Small-Cell Lung/mortality; Carcinoma, Squamous Cell/mortality; Female; Follow-Up Studies; Humans; Lung Neoplasms/mortality; Male; Maximum Tolerated Dose; Middle Aged; Survival Rate; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Adenocarcinoma / Salvage Therapy / Carcinoma, Large Cell / Carcinoma, Non-Small-Cell Lung / Furans / Ketones / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google